2022-11116: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers; Extension of Comment Period

Summary

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule on national standards for licensure for wholesale drug distributors and third-party logistics providers that appeared in the Federal Register of February 4, 2022. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.

The agency’s own summary, as published.

What this changes

Amends 4 parts of the Code of Federal Regulations — the standing rules this notice rewrites.

• 21 CFR 10 Administrative Practices and Procedures
• 21 CFR 12 Formal Evidentiary Public Hearing
• 21 CFR 16 Regulatory Hearing Before the Food and Drug Administration
• 21 CFR 205 Guidelines for State Licensing of Wholesale Prescription Drug Distributors